Logo Logo

ERC Grants > ERC Grant 675074: Protein-excipient Interactions and Protein-Protein Interactions in formulation - PIPPI

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
  • Collection (5)
    • ERC Grants (5)
      • ERC Grant 675074: Protein-excipient Interactions and Protein-Protein Interactions in formulation - PIPPI (5)
Group by: Date | Creators | Item Type | Language | Volume
Jump to: 2019 | 2018
Number of items at this level: 5.

2019

Gentiluomo, Lorenzo; Roessner, Dierk; Augustijn, Dillen; Svilenov, Hristo ORCID: 0000-0001-5863-9569; Kulakova, Alina; Mahapatra, Sujata; Winter, Gerhard; Streicher, Werner; Rinnan, Asmund; Peters, Günther; Harris, Pernille; Friess, Wolfgang (August 2019): Application of interpretable artificial neural networks to early monoclonal antibodies development. In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 141: pp. 81-89 [PDF, 1MB]

Svilenov, Hristo ORCID: 0000-0001-5863-9569; Winter, Gerhard (1. May 2019): Rapid sample-saving biophysical characterisation and long-term storage stability of liquid interferon alpha2a formulations Is there a correlation? In: International Journal of Pharmaceutics, Vol. 562: pp. 42-50 [PDF, 1MB]

Svilenov, Hristo ORCID: 0000-0001-5863-9569; Winter, Gerhard (April 2019): The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage. In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 137: pp. 131-139 [PDF, 2MB]

2018

Svilenov, Hristo ORCID: 0000-0001-5863-9569; Gentiluomo, Lorenzo; Friess, Wolfgang; Roessner, Dierk; Winter, Gerhard (December 2018): A New Approach to Study the Physical Stability of Monoclonal Antibody Formulations Dilution From a Denaturant. In: Journal of Pharmaceutical Sciences, Vol. 107, No. 12: pp. 3007-3013 [PDF, 1MB]

Svilenov, Hristo ORCID: 0000-0001-5863-9569; Markoja, Uros; Winter, Gerhard (April 2018): Isothermal chemical denaturation as a complementary tool to overcome limitations of thermal differential scanning fluorimetry in predicting physical stability of protein formulations. In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 125: pp. 106-113 [PDF, 1MB]

This list was generated on Sat Nov 23 04:14:57 2019 CET.